HCAFX
Price
$48.84
Change
+$0.16 (+0.33%)
Updated
Jun 2 closing price
Net Assets
6.4B
VFIAX
Price
$698.33
Change
-$5.17 (-0.73%)
Updated
Jun 3 closing price
Net Assets
1.6T
Interact to see
Advertisement

HCAFX vs VFIAX

Header iconHCAFX vs VFIAX Comparison
Open Charts HCAFX vs VFIAXBanner chart's image
HCAFX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
HCAFX vs. VFIAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAFX is a StrongBuy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.6T vs. HCAFX (6.4B). VFIAX pays higher dividends than HCAFX: VFIAX (1.02) vs HCAFX (0.55). HCAFX was incepted earlier than VFIAX: HCAFX (9 years) vs VFIAX (26 years). HCAFX (0.70) is less costly to investors than VFIAX (0.04). HCAFX is a more actively managed with annual turnover of: 94.00 vs. VFIAX (2.00). VFIAX has a lower initial minimum investment than HCAFX: VFIAX (3000) vs HCAFX (1000000). VFIAX annual gain was more profitable for investors over the last year : 27.49 vs. HCAFX (16.41). VFIAX return over 5 years is better than : 80.01 vs. HCAFX (7.97).
HCAFXVFIAXHCAFX / VFIAX
Total Expense Ratio0.700.041,750%
Annual Report Gross Expense Ratio0.700.041,750%
Fund Existence9 years26 years-
Gain YTD9.73911.35186%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.4B1.6T0%
Annual Yield % from dividends0.551.0254%
Returns for 1 year16.4127.4960%
Returns for 3 years38.1477.8249%
Returns for 5 years7.9780.0110%
Returns for 10 yearsN/A262.58-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRBS3.280.02
+0.61%
Blue Ridge Bankshares
RITR0.50-0.01
-2.73%
Reitar Logtech Holdings Ltd.
UBER71.62-2.15
-2.91%
Uber Technologies
INBX93.73-5.56
-5.60%
Inhibrx Biosciences Inc.
OSCR21.14-1.83
-7.97%
Oscar Health